NDTVCenter·
Dr. Reddy's Gets Double Blow After Q1: Rating Downgrade, Target Price Cut By Dolat Capital — Here's Why
The quarter included a provision of Rs 240 crore towards inventory and other associated costs related to Semaglutide API.
Read at NDTV →




